BridgeMD
New treatment option for Cancer
Official title Enhancing Successful Return to Work of Employees With Cancer, by Supporting Employers (MiLES Intervention)
ClinicalTrials.gov ID: NCT06672887
What this study is testing
- What it's testing
- The objective of this randomized controlled trial (RCT) is to evaluate the effectiveness of the MiLES intervention targeted at employers, on successful return to work (RTW) of employees with cancer, compared to care as usual (CAU). Secundary objectives are: To evaluate the cost-effectiveness and return-on-investment of the MiLES intervention on successful RTW and quality of life, compared to CAU.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- employees with cancer:
- Diagnosed with cancer \<2 years earlier;
- Being of working age (between 18-65 years, considering the Dutch retirement age of 67 years, and the study's follow-up period of one year);
- In paid employment with an employer;
- Having either an occupational physician at the involved occupational health service or a reintegration consultant at the involved reintegration...
You likely can't join if
- \- Employees with cancer and their employers must participate as a dyad. If one party in the dyad is unable or unwilling to participate, the other...
See the full eligibility criteria
- employees with cancer:
- Diagnosed with cancer \<2 years earlier;
- Being of working age (between 18-65 years, considering the Dutch retirement age of 67 years, and the study's follow-up period of one year);
- In paid employment with an employer;
- Having either an occupational physician at the involved occupational health service or a reintegration consultant at the involved reintegration service (e.g. working for an organization that is affiliated with one of...
- Currently fully or partly sick-listed (\<2 years);
- Able to understand and read Dutch for filling out questionnaires;
- Having already informed their employer about their diagnosis of cancer, or intending to do so;
- Not yet applied or planning to apply for an invalidity benefit under the WIA. employers:
- Supports and guides the participating employee with cancer during the period of sick leave and RTW. For example, as the direct supervisor or HR-manager;
- Able to understand and read Dutch to be able to use the MiLES intervention and for filling out questionnaires;
- Not yet familiar with the MiLES intervention.
- \- Employees with cancer and their employers must participate as a dyad. If one party in the dyad is unable or unwilling to participate, the other party cannot participate either.
The study team makes the final eligibility decision.
Where it's taking place
- Arnhem, Netherlands
- Dordrecht, Netherlands
- Hengelo, Netherlands
- Utrecht, Netherlands
- Zeeland, Netherlands
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Arnhem, Netherlands; Dordrecht, Netherlands; Hengelo, Netherlands; Utrecht, Netherlands; Zeeland, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.